S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Laser breakthrough could send stock soaring 2,467% (Ad)
2 Stocks to Benefit from the Aging Population
3 Warren Buffett Stocks that are Moving into the Buy Zone
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
3 Stocks That Really, Really Need the Defense Bill to Pass
Laser breakthrough could send stock soaring 2,467% (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Laser breakthrough could send stock soaring 2,467% (Ad)
2 Stocks to Benefit from the Aging Population
3 Warren Buffett Stocks that are Moving into the Buy Zone
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
3 Stocks That Really, Really Need the Defense Bill to Pass
Laser breakthrough could send stock soaring 2,467% (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Laser breakthrough could send stock soaring 2,467% (Ad)
2 Stocks to Benefit from the Aging Population
3 Warren Buffett Stocks that are Moving into the Buy Zone
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
3 Stocks That Really, Really Need the Defense Bill to Pass
Laser breakthrough could send stock soaring 2,467% (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Hanes Worth More than the Sum of Its Parts?
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Laser breakthrough could send stock soaring 2,467% (Ad)
2 Stocks to Benefit from the Aging Population
3 Warren Buffett Stocks that are Moving into the Buy Zone
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Reasons Unity Software Is Ready to Rally 38%
3 Stocks That Really, Really Need the Defense Bill to Pass
Laser breakthrough could send stock soaring 2,467% (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Is Hanes Worth More than the Sum of Its Parts?
OTCMKTS:CCEL

Cryo-Cell International (CCEL) Stock Forecast, Price & News

$5.28
0.00 (0.00%)
(As of 09/26/2023 ET)
Compare
Today's Range
$5.17
$5.50
50-Day Range
$5.03
$6.31
52-Week Range
$2.69
$7.25
Volume
14,514 shs
Average Volume
10,057 shs
Market Capitalization
$43.77 million
P/E Ratio
18.86
Dividend Yield
N/A
Price Target
N/A

CCEL stock logo

About Cryo-Cell International (OTCMKTS:CCEL) Stock

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

CCEL Price History

CCEL Stock News Headlines

The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
CPS Technologies CEO resigns
Cell Banking Outsourcing Market Outlook by 2031
CCEL Cryo-Cell International, Inc.
See More Headlines
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Company Calendar

Last Earnings
7/14/2023
Today
9/26/2023
Next Earnings (Estimated)
10/12/2023
Fiscal Year End
11/30/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CCEL
Employees
80
Year Founded
N/A

Profitability

Net Income
$2.77 million
Pretax Margin
9.09%

Debt

Sales & Book Value

Annual Sales
$30.34 million
Cash Flow
$0.54 per share
Book Value
($0.18) per share

Miscellaneous

Free Float
5,382,000
Market Cap
$43.77 million
Optionable
Not Optionable
Beta
0.33
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. David I. PortnoyMr. David I. Portnoy (Age 60)
    Chairman & Co-CEO
    Comp: $1.07M
  • Mr. Mark L. Portnoy (Age 59)
    Co-CEO & Director
    Comp: $764k
  • Ms. Jill M. Taymans (Age 53)
    CFO & VP of Fin.
    Comp: $227.99k
  • Mr. Oleg Mikulinsky (Age 50)
    Chief Information Officer
    Comp: $360k
  • Dr. Joanne Kurtzberg M.D.
    Medical Director and Member of Medical & Scientific Advisory Board













CCEL Stock - Frequently Asked Questions

How have CCEL shares performed in 2023?

Cryo-Cell International's stock was trading at $4.23 at the start of the year. Since then, CCEL stock has increased by 24.8% and is now trading at $5.28.
View the best growth stocks for 2023 here
.

When is Cryo-Cell International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 12th 2023.
View our CCEL earnings forecast
.

How were Cryo-Cell International's earnings last quarter?

Cryo-Cell International, Inc. (OTCMKTS:CCEL) issued its quarterly earnings results on Friday, July, 14th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.10. The business had revenue of $7.77 million for the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 168.11% and a net margin of 7.38%.

What other stocks do shareholders of Cryo-Cell International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Platforms (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?

Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."

How do I buy shares of Cryo-Cell International?

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryo-Cell International's stock price today?

One share of CCEL stock can currently be purchased for approximately $5.28.

How much money does Cryo-Cell International make?

Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $43.77 million and generates $30.34 million in revenue each year. The company earns $2.77 million in net income (profit) each year or $0.28 on an earnings per share basis.

How can I contact Cryo-Cell International?

Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745.

This page (OTCMKTS:CCEL) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -